Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tetrahydrouridine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 1114 Specimen Handling 744 Carboplatin 741 Cyclophosphamide 715 Magnetic Resonance Spectroscopy 695 Cisplatin 636 Nivolumab 608 Paclitaxel 558 Radiotherapy 498 Gemcitabine 490 Biopsy 456 Bevacizumab 412 Dexamethasone 394 fludarabine 349 Docetaxel 346 venetoclax 340 Fluorouracil 323 Oxaliplatin 323 atezolizumab 319 Capecitabine 316 Rituximab 312 durvalumab 296 Doxorubicin 281 Pemetrexed 279 Radiosurgery 273 Drug Therapy 270 Ipilimumab 270 Standard of Care 261 Lenalidomide 252 Radiation 252

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01534598 2026-02-10

FdCyd and THU for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡